Scholarlink

Objectives <p>To evaluate the association between prior community-based antibiotic treatment for acute otitis media (AOM) and the incidence and severity of complications in children hospitalized with acute mastoiditis (AM), noting that this design does not address whether prior antibiotic treatment prevents AM development.</p> Methods <p>This retrospective cohort study analyzed medical records of 522 children (age &lt; 15 years) diagnosed with AM at a tertiary medical center between 2015 and 2025. Children were categorized by prior antibiotic exposure: those receiving antibiotics for &gt; 48&#xa0;h before hospitalization versus those receiving &lt; 48&#xa0;h or none. The primary outcome was the presence of complicated AM, defined as extracranial (subperiosteal abscess) or intracranial (epidural abscess, sigmoid sinus thrombosis, brain abscess, or meningitis) complications.</p> Results <p>Of 522 children, 110 (21%) received prior antibiotics and 412 (79%) did not. While the composite complication rate was higher in the prior treatment group (54.5% vs. 38.6%, unadjusted OR = 1.91, <i>p</i> = 0.003), prior antibiotic treatment was not significantly associated with specific complication types, including subperiosteal abscess (adjusted OR = 0.67, <i>p</i> = 0.37) or intracranial complications (adjusted OR = 1.74, <i>p</i> = 0.13). Inflammatory markers, hospitalization length, imaging use, and surgical intervention rates were comparable between groups. Fusobacterium necrophorum in blood cultures was significantly associated with complications regardless of prior antibiotic exposure.</p> Conclusions <p>Among children hospitalized with AM, prior antibiotic treatment was not associated with increased rates of specific complications. The difference in composite outcomes likely reflects selection bias rather than a true treatment effect. Causal inference is limited by confounding by indication and unmeasured baseline severity differences.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Incidence of mastoiditis complications in relation to prior community-based antibiotic treatment

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月1日

查看全文
  • Nitzan Sofer,
  • Ayalon Hadar,
  • Gabriel Choucroun,
  • Yehuda Tarnovsky,
  • Ronen Perez,
  • Pierre Attal,
  • Chanan Shaul

摘要

Objectives

To evaluate the association between prior community-based antibiotic treatment for acute otitis media (AOM) and the incidence and severity of complications in children hospitalized with acute mastoiditis (AM), noting that this design does not address whether prior antibiotic treatment prevents AM development.

Methods

This retrospective cohort study analyzed medical records of 522 children (age < 15 years) diagnosed with AM at a tertiary medical center between 2015 and 2025. Children were categorized by prior antibiotic exposure: those receiving antibiotics for > 48 h before hospitalization versus those receiving < 48 h or none. The primary outcome was the presence of complicated AM, defined as extracranial (subperiosteal abscess) or intracranial (epidural abscess, sigmoid sinus thrombosis, brain abscess, or meningitis) complications.

Results

Of 522 children, 110 (21%) received prior antibiotics and 412 (79%) did not. While the composite complication rate was higher in the prior treatment group (54.5% vs. 38.6%, unadjusted OR = 1.91, p = 0.003), prior antibiotic treatment was not significantly associated with specific complication types, including subperiosteal abscess (adjusted OR = 0.67, p = 0.37) or intracranial complications (adjusted OR = 1.74, p = 0.13). Inflammatory markers, hospitalization length, imaging use, and surgical intervention rates were comparable between groups. Fusobacterium necrophorum in blood cultures was significantly associated with complications regardless of prior antibiotic exposure.

Conclusions

Among children hospitalized with AM, prior antibiotic treatment was not associated with increased rates of specific complications. The difference in composite outcomes likely reflects selection bias rather than a true treatment effect. Causal inference is limited by confounding by indication and unmeasured baseline severity differences.